Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMLCG 2008: S-HAM vs Standard Double Induction in AML
NCT01382147Phase 3Completed
- Start
- Jul 2009
- Primary completion
- Aug 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of cytarabine, mitoxantrone in acute myeloid leukemia (AML). Started Jul 2009; status: completed.
02
Drugs
cytarabinemitoxantrone
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01382147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01382147.